Llorens Josep's Form 4 filing
Haemonetics Corp (HAE) · filed Sep 9, 2021
- Accession no.
- 0000899243-21-035451
- Filed
- Sep 9, 2021
- Trade date
- Sep 7, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $6.46K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Llorens JosepCIK 0001750812 | Officer (EVP, Global Manufacturing) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 | Common Stock | SSaleDisposed | −100 | $64.61 | −$6,461 | 14,520 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.